News & Publications

Merkel cell carcinoma (MCC) is an aggressive skin cancer that recurs in more than one-third of cases, with reported mortality rates of 33%to 46%.1 Given this high risk situation, MCC is often managed with therapies that are aggressive and potentially toxic: extensive surgery, radiation therapy (RT),...

In October 2017, a multidisciplinary symposium on new developments in the comprehensive management of Merkel cell carcinoma was held at the University of Rochester Medical Center. The event included specialists across many disciplines such as dermatology, surgical oncology, otolaryngology, radiation...

The fund supports patients who have been diagnosed with the rare form of skin cancer known as Merkel Cell Carcinoma (MCC). Once approved, the financial fund provides one-time assistance of $450 to cover transportation-related expenses connected to treatment appointments. Eligible patients include th...

BACKGROUND: Merkel cell carcinoma (MCC) is a rare and aggressive type of cancer with poor outcomes. OBJECTIVE: To describe treatment patterns, overall survival, and healthcare costs associated with advanced MCC (aMCC) using data from Medicare enrollees who received an aMCC diagnosis in the USA State...

Published data for pediatric and young adult patients with Merkel cell carcinoma (MCC) are scarce. Case reports from the United States and Europe suggest that MCC can occur in young persons and may be more aggressive in this setting. We sought to determine the frequency of MCC in pediatric and young...

This year's annual meeting of the Society for Investigative Dermatology took place in Chicago, Illinois from May 8-11, 2019 where members of the Nghiem Lab team had the opportunity to present their latest MCC research.

American Academy of Dermatology Annual Meeting Washington, DC Prepared by Song Park, Paul Nghiem, Tomoko Akaike and Coley Doolittle-Amieva Announcements: 1) 1st International Symposium on Merkel Cell Carcinoma – October 21-22, 2019, Moffitt Cancer Canter, Tampa, FL This conference is a fi...

It was a very exciting time for Merkel cell research at this years annual meeting of the Society for Investigative Dermatology which took place in Chicago, Illinois from May 8-11, 2019. Neha Singh, a research scientist working under Dr. Paul Nghiem, presented her recent findings that suggest bas...

Dr. Nghiem attended the 2019 EADO Congress in Paris, France that took place April 24-27, 2019. He spoke about progress being made in MCC therapies and proposed less toxic and more effective interventions. See below to hear more about the exciting progress being made. https://www.youtube.com/watc...

Photo Source Robert Royer lost his year-long battle with Merkel cell carcinoma on April 17, 2019, in the setting of also having chronic lymphocytic leukemia (CLL). Mr. Royer was a passionate civic leader, serving as deputy mayor for the city of Seattle from 1978 to 1983. To read the Seattle Times...